| Financial Year |
March 31 2023 |
| Monetary Funds |
120,972,833.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
389,959,885.29 |
| Advances to Suppliers |
17,374,097.55 |
| Other Receivables |
148,449,619.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,800,608.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,093,325.70 |
| Total Current Assets |
800,338,151.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
25,468,152.17 |
| Fixed Assetes |
703,696,122.23 |
| Under-construction Projects |
70,370,713.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,938,442.57 |
| R&D expenses |
-- |
| Goodwill |
36,762,945.00 |
| Long-Term Deferred and Prepaid Expenses |
180,882,823.17 |
| Deferred Income Tax Assets |
31,186,247.30 |
| Other Non-Current Assets |
16,448,825.68 |
| Sub-Total of Non-Current Assets |
1,107,866,871.90 |
| Total Assets |
1,908,205,023.51 |
| Short-Term Loans |
529,426,708.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
75,000,000.00 |
| Accounts Payable |
185,187,384.09 |
| Accounts Received In Advance |
9,207,482.73 |
| Employee Compensation Payable |
11,679,907.42 |
| Taxes Payable |
36,483,267.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,945,254.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,354,349.39 |
| Other Current Liabilities |
868,147.25 |
| Sub-Total of Current Liabilities |
940,609,713.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
60,131,559.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,465,994.15 |
| Total Liabilities |
1,067,075,707.98 |
| Paid-In Capital(Or Share Stock) |
202,800,000.00 |
| Capital Surplus |
140,904,233.28 |
| Surplus Reserve |
23,117,995.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
466,554,115.93 |
| Minority Stockholder's Interest |
7,752,971.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
833,376,344.38 |
| Owner's Equity（Stockholder's Equity） |
841,129,315.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,908,205,023.51 |
